EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance

Ryo Okuda iD, Tamiko Takemura, Toshihiro Misumi, Eri Hagiwara, Takashi Ogura

Journal of Asthma and Allergy · 2023-05 · Volume 16 · 473-479

DOI: 10.2147/jaa.s409042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Asthma and Allergy, 2023-05. Verfasst von Ryo Okuda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the two fibrotic hypersensitivity pneumonitis (fHP) diagnostic guidelines, the multidisciplinary discussion (MDD) is required to be performed in diagnosis of fHP, as in idiopathic pulmonary fibrosis (IPF) diagnostic guideline. Although some patients with fHP can improve disease condition during antigen avoidance, which can facilitate the diagnosis of fHP, it is unclear if MDD is necessary in all patients with suspected fHP who improved an antigen avoidance.

Objective

To investigate the diagnosis of fHP via MDD with positive antigen avoidance tests (AATs) and the clinical diagnosis with positive AATs.

Methods

A single-center, retrospective study was conducted. Between 2012 and 2019, patients with fHP were enrolled in the study. Patients in the MDD diagnostic group consisted of patients diagnosed with MDD, including histopathology findings and positive ATTs, and patients in the clinical diagnostic group were diagnosed by two respiratory physicians and had positive ATTs.

Results

AAT was performed on 72 of 219 patients, and 58 had positive AATs. The study included 37 patients in the MDD diagnosis group and 21 patients in the clinical diagnosis group. No significant differences in overall survival (OS) were detected between the two groups (HR: 1.99 [95% CI: 0.82‒4.83], p = 0.127). The conducting MDD was not a risk factor for OS; only

Schlagwörter

Stichwörter der Autor:innen

chronic hypersensitivity pneumonitisdiagnostic methodhypersensitivity pneumonitismultidisciplinary teamsubacute hypersensitivity pneumonitis

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
  • Department of Pathology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
  • Department of Data Science, National Cancer Center Hospital East, Chiba, Japan.

ORCID-Profile: Ryo Okuda

Zitieren

APA

Okuda, R., Takemura, T., Misumi, T., Hagiwara, E., & Ogura, T. (2023). Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance. Journal of Asthma and Allergy, Volume 16, 473-479. https://doi.org/10.2147/jaa.s409042

Vancouver

Okuda R, Takemura T, Misumi T, Hagiwara E, Ogura T. Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance. Journal of Asthma and Allergy. 2023;Volume 16:473-479. doi:10.2147/jaa.s409042

BibTeX
@article{Okuda2023,
  author = {Okuda, Ryo and Takemura, Tamiko and Misumi, Toshihiro and Hagiwara, Eri and Ogura, Takashi},
  title = {Multidisciplinary Discussion for Fibrotic Hypersensitivity Pneumonitis with a Positive Antigen Avoidance},
  journal = {Journal of Asthma and Allergy},
  year = {2023},
  volume = {Volume 16},
  pages = {473--479},
  doi = {10.2147/jaa.s409042}
}
Kostenlos starten →